Maky Zanganeh Summit Therapeutics Inc. (SMMT) insider trading activity

Maky Zanganeh is Co-Chief Executive Officer of Summit Therapeutics Inc.. Currently has a direct ownership of 520,814 shares of SMMT, which is worth approximately $9.31 Million. The most recent transaction as insider was on Mar 27, 2024, when has been sold 26,000 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $96,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 521K

0% 3M change

5.25% 12M change

Total Value Held $9.31 Million

Maky Zanganeh Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 27 2024	BUY Open market or private purchase	$96,720 $3.72 p/Share	26,000 Added 4.75%	520,814 Common Stock
Dec 12 2023	BUY Open market or private purchase	$10,350 $2.07 p/Share	5,000 Added 1.0%	494,814 Common Stock
Dec 11 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	$705,332 $1.44 p/Share	489,814 Added 50.0%	489,814 Common Stock
Mar 08 2023	BUY Open market or private purchase	$16,772,430 $1.05 p/Share	15,973,743 Added 40.57%	23,395,269 Common Stock
Dec 06 2022	BUY Other acquisition or disposition	-	373,857 Added 3.31%	10,930,849 Common Stock
Aug 16 2022	BUY Open market or private purchase	$178,897 $0.97 p/Share	184,430 Added 33.88%	359,969 Common Stock

Also insider at

PLSE

Pulse Biosciences, Inc. Healthcare

Director

Maky Zanganeh

Co-Chief Executive Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMMT shares.

Notify only if

Value

Insider Trading

Get notified when an Summit Therapeutics Inc. insider buys or sells SMMT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Summit Therapeutics Inc.

Track Activities on SMMT

Account